-A +A

LBD in the News

Below are links to LBD-related news articles. We also offer a substantial list of research abstracts and continuing medical education (CME) resources.

While every effort has been made to provide current information and working links, sometimes links expire or move. If you find a broken link, incorrect information, or would like to recommend a article for this page, please let us know by sending an email with the pertinent information. Thank you for your assistance.
 

06/29/2011 - GE Healthcare announced recently the availability of DaTscan™ (Ioflupane I 123 Injection), in more than 80 hospitals across the US. DaTscan is the first FDA-approved radiopharmaceutical adjunct imaging agent to help physicians evaluate patients with suspected parkinsonian syndromes, such as Parkinson's disease (PD). 

05/11/2011 - Scientists studying alpha-synuclein, the protein involved in Lewy body dementia and Parkinson’s disease, have found that in its natural, healthy state the protein has a radically different structure than previously thought.

02/25/2011 - What happens when a beautifully sharp mind begins to unravel? Beth Macy follows the dark descent of an unlikely victim of Lewy body dementia in the March, 2011 issue of O Magazine.

01/31/2011 - The FDA approves the first diagnostic imaging agent to aid in the diagnosis of progressive movement disorders.

01/24/2011 - A recently published research paper by the European Journal of Neurology indicates that the presence of adult ADHD symptoms poses a 3-fold risk of developing DLB, but the LBDA Scientific Advisory Council has expressed concern that the conclusions drawn are premature.

01/11/2011 - Quality clinical care of Parkinson’s disease, with or without accompanying dementia, includes much more than treating movement symptoms.

10/25/2010 - Dementia family caregivers are invited to participate in a study funded by the National Institute on Aging about a new educational and support website on dementia and caregiving.

10/13/2010 - The Michael J. Fox Foundation recently launched the Parkinson’s Progression Markers Initiative (PPMI), a landmark clinical study to identify and validate Parkinson’s disease biomarkers.

10/08/2010 - ADNI GO, a landmark research study sponsored by the National Institute on Aging (NIA) at the National Institutes of Health (NIH), is examining the sequence and timing of events at the initial onset of mild cognitive symptoms.

09/29/2010 - New York University specialty clinic will offer leading-edge LBD diagnostic and treatment services.